HomeInvestor DirectoryComputational BiologyMicah Siegel
MS
Micah Siegel
Managing Director at C2C Ventures · Silicon Valley, California
Check size
Seed-stage
Lead stage
pre-seed
Deals tracked
24
Sectors
Computational Biology, Enterprise Software
Computational Biology Enterprise Software Scientific Instruments AI Systems Molecular Biology Tools Software and Hardware Technologies pre-seed seed Pre-seed Seed
United States Canada

About Micah
Micah Siegel is a venture capital investor based in Palo Alto, CA, with affiliations to Concept2Company Ventures and Vanedge Capital. He is a former Stanford Professor whose research focused on discovering commercial applications of AI, including new software and hardware technologies in engineering and the life sciences
Investment thesis
Helps founders discover attractive markets for new technologies and secure rich customers who will move fast and pay a premium.
Micah Siegel invests in early-stage technology companies with foundational technologies, particularly those formed by academic founders and students with limited business experience. He focuses on identifying companies in computational biology, enterprise software, scientific instruments, and AI systems that target large markets ($1B+ potential) and can secure premium-paying customers willing to move fast. His approach emphasizes partnering with missionary entrepreneurs at the earliest stage to provide trusted capital and strategic advice for commercializing breakthrough technologies developed at universities
Investment philosophy
Micah is an active investor in new technology companies formed by students, faculty, and former students at the earliest stage (often before there is a company) through his private venture capital fund, C2C Ventures, where he is the sole Managing Director. His engineering research focused primarily on finding commercial applications of new software and hardware technologies, such as scientific instrumentation, molecular biology tools and AI systems.
Investment focus
Early-stage ventures at the intersection of AI, software, and hardware technologies with applications in engineering and life sciences. Leverages academic research background to identify commercially viable deep-tech opportunities
Areas of expertise
Deep Tech AI/ML Hardware Life Sciences Engineering
Recent activity
2010 Started 2010; acquired 2021 by Prosus for $1.8 billion in cash
2013 Started at Stanford 2013; acquired 2015 by Becton Dickinson for $120 million in cash
2013 Started at Disqus in 2013
2003 Started at UCLA 2003; acquired 2010 by Roche for $100 million in cash
2012 Started at Stanford 2012; acquired 2020 by FastCase
Live platform data · proprietary, citable layer
Notable portfolio
Stack Overflow Cellular Research Sentry BioImagene Judicata Hadapt C2C Patents Affinity Engines Adapt Technologies Gusto Notion Visby Medical Pulse Katango Stack Overflow (acq. Prosus $1.8B)

Frequently asked
Does Micah Siegel invest at pre-seed stage?
Yes. They invest at pre-seed, seed, Pre-seed stage. Their geographic focus includes United States, Canada.
What is their typical check size?
Micah Siegel's typical check size is Seed-stage. They currently invest through C2C Ventures.
What sectors does Micah Siegel focus on?
Micah Siegel primarily invests in Computational Biology, Enterprise Software, Scientific Instruments, AI Systems.
Are you a fit for Micah Siegel?
See your match score free · under a minute
Check my fit free